In the Journals

Epiretinal membrane surgery successful in eyes with or without high myopia

Epiretinal membrane surgery yielded similar anatomic and visual outcomes and complication rates in highly myopic and non-highly myopic eyes without traction maculopathy, according to a study.

The retrospective study included 509 eyes of 509 patients who underwent pars plana vitrectomy with epiretinal membrane (ERM) removal. Investigators analyzed 32 eyes with more than 6 D of myopia that underwent isolated ERM removal. A control group comprised 64 eyes without high myopia that underwent ERM removal. Matching was based on age, preoperative visual acuity, year of surgery and gauge of the vitrectomy system used in surgery.

Mean patient age was 59.88 years in the highly myopic group and 68.73 years in the remaining cohort.

Primary outcome measures were mean best corrected visual acuity, central macular thickness and complications. Mean follow-up was 3.2 years for the study group and 3.4 years for controls.

Mean BCVA improved from 0.56 to 0.26 in the study group and 0.54 to 0.22 in the control group; both gains were statistically significant (P < .001).

Mean central macular thickness improved from 433 µm to 314 µm in the study group and 428 µm to 303 µm in the control group (both P < .001).

Complication rates were similar in both groups, according to the authors.

Disclosure: The study authors report no relevant financial disclosures.

Epiretinal membrane surgery yielded similar anatomic and visual outcomes and complication rates in highly myopic and non-highly myopic eyes without traction maculopathy, according to a study.

The retrospective study included 509 eyes of 509 patients who underwent pars plana vitrectomy with epiretinal membrane (ERM) removal. Investigators analyzed 32 eyes with more than 6 D of myopia that underwent isolated ERM removal. A control group comprised 64 eyes without high myopia that underwent ERM removal. Matching was based on age, preoperative visual acuity, year of surgery and gauge of the vitrectomy system used in surgery.

Mean patient age was 59.88 years in the highly myopic group and 68.73 years in the remaining cohort.

Primary outcome measures were mean best corrected visual acuity, central macular thickness and complications. Mean follow-up was 3.2 years for the study group and 3.4 years for controls.

Mean BCVA improved from 0.56 to 0.26 in the study group and 0.54 to 0.22 in the control group; both gains were statistically significant (P < .001).

Mean central macular thickness improved from 433 µm to 314 µm in the study group and 428 µm to 303 µm in the control group (both P < .001).

Complication rates were similar in both groups, according to the authors.

Disclosure: The study authors report no relevant financial disclosures.